273.45
-5.55
(-1.99%)
At close: January 10 at 2:15:01 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,816,171.00
1,972,412.00
1,830,485.00
2,000,466.00
1,815,670.00
Cost of Revenue
1,462,255.00
1,546,247.00
1,541,174.00
1,662,273.00
1,339,392.00
Gross Profit
353,916.00
426,165.00
289,311.00
338,193.00
476,278.00
Operating Expense
352,301.00
366,722.00
316,126.00
295,311.00
276,015.00
Operating Income
1,615.00
59,443.00
-26,815.00
42,882.00
200,263.00
Net Non Operating Interest Income Expense
-52,326.00
-53,695.00
-32,748.00
-30,488.00
-31,470.00
Pretax Income
-50,283.00
6,104.00
899.00
17,393.00
172,736.00
Tax Provision
2,465.00
4,712.00
2,721.00
5,956.00
35,586.00
Net Income Common Stockholders
-52,748.00
1,392.00
-1,822.00
11,437.00
137,150.00
Diluted NI Available to Com Stockholders
-52,748.00
1,392.00
-1,822.00
11,437.00
137,150.00
Basic EPS
-6.60
0.17
-0.23
1.43
17.14
Diluted EPS
-6.60
0.17
-0.23
1.43
17.14
Basic Average Shares
8,148.79
8,188.24
7,921.74
7,997.90
8,001.75
Diluted Average Shares
8,148.79
8,188.24
7,921.74
7,997.90
8,001.75
Rent Expense Supplemental
--
10,609.00
5,591.00
4,607.00
3,206.00
Total Expenses
1,814,556.00
1,912,969.00
1,857,300.00
1,957,584.00
1,615,407.00
Net Income from Continuing & Discontinued Operation
-52,748.00
1,392.00
-1,822.00
11,437.00
137,150.00
Normalized Income
-52,748.00
1,392.00
-37,183.90
11,437.00
137,150.00
Interest Income
--
969.00
348.00
540.00
1,094.00
Interest Expense
47,059.00
48,428.00
29,388.00
26,162.00
20,114.00
Net Interest Income
-52,326.00
-53,695.00
-32,748.00
-30,488.00
-31,470.00
EBIT
-3,224.00
54,532.00
30,287.00
43,555.00
192,850.00
EBITDA
57,961.00
112,490.00
75,027.00
81,522.00
226,596.00
Reconciled Cost of Revenue
1,462,255.00
1,546,247.00
1,541,174.00
1,662,273.00
1,339,392.00
Reconciled Depreciation
61,185.00
57,958.00
44,740.00
37,967.00
33,746.00
Net Income from Continuing Operation Net Minority Interest
-52,748.00
1,392.00
-1,822.00
11,437.00
137,150.00
Total Unusual Items Excluding Goodwill
--
--
50,517.00
--
--
Total Unusual Items
--
--
50,517.00
--
--
Normalized EBITDA
57,961.00
112,490.00
24,510.00
81,522.00
226,596.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
15,155.10
--
--
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DECCAN.BO Deccan Health Care Ltd
29.19
-2.70%
EMMESSA.BO Emmessar Biotech & Nutrition Limited
43.30
-2.61%
MAKERSL.BO Makers Laboratories Limited
179.95
-1.56%
MOREPENLAB.BO Morepen Laboratories Limited
68.22
-3.75%
MEGASOFT.NS Megasoft Limited
99.10
-5.00%
PPLPHARMA.NS Piramal Pharma Limited
221.25
-6.70%